

Manage your blood sugar level with RUBELSUS
(edit with the Customer Reassurance module)
(edit with the Customer Reassurance module)
(edit with the Customer Reassurance module)
RYBELSUS semaglutide tablets
INTRODUCING RYBELSUS®, THE FIRST AND ONLY ORAL GLP-1 RA*
Dear healthcare professional,
Novo Nordisk is pleased to announce the launch of RYBELSUS® in Canada! RYBELSUS® (semaglutide tablets) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus:1
- as monotherapy when metformin is considered inappropriate due to intolerance or contraindications
- in combination with other medicinal products for the treatment of diabetes (see clinical trials in the Product Monograph for patient populations and drug combinations tested